Gastroenterology

Gastrointestinal health concerns such as gastritis, irritable bowel symptoms, constipation, and diarrhoea affect millions of Indians, significantly impacting comfort and daily life. Epidemiological research shows that gastrointestinal issues are reported by nearly 18% of adults in India, underscoring a substantial burden on individuals and families seeking timely and quality care (1).

At Medley Pharmaceuticals, our gastroenterology focus is driven through the SUPRAKARE Division, which delivers comprehensive solutions across key sub-therapies including Antiulcerants, Prokinetics, PPI–Prokinetic combinations, Constipation management, Digestive Enzymes, Anti-diarrhoeal, and Hepatoprotective therapies. Our balanced and evidence-based portfolio is designed to support effective disease management across the entire gastrointestinal spectrum.

Recognised as the No. 1 division of Medley as per CMARC Nov–Dec ’25 data (2), SUPRAKARE reflects the confidence of healthcare professionals and the trust of patients nationwide. We remain committed to advancing gastrointestinal care through quality medicines, scientific excellence, and patient-focused solutions that improve long-term clinical outcomes and everyday well-being.